In vivo Ki67 experiments demonstrated that AML-IRF7−/−-TGIF1 cells had increased levels of G0 phase cells but decreased levels of G1 and S/G2/M phase cells (Fig. 4H). Here, TGIF1 is linked to acute myeloid leukemia.